GE Healthcare IMAC Sepharose™ 6 Fast Flow Affinity Media Available on GSA/VA Contract for Federal Government customers only.

Used for purifying proteins and peptides that have an affinity for metal ions. GE Healthcare IMAC Sepharose 6 Fast Flow is composed of cross-linked 6% agarose beads modified with a novel chelating ligand immobilized to the base matrix.

Manufacturer: GE Healthcare 17092108

 View more versions of this product

Catalog No. 45-002-967

  Check Availability
Add to Cart


    Flow Rate 250 to 400cm/Hour
    For Use With (Application) For purifying proteins and peptides that have an affinity for metal ions
    Height (English) Bed 9.84 in.
    Height (Metric) Bed 25cm
    Matrix 6% Cross-Linked Agarose
    Max. Pressure 100kPa
    Quantity 100mL
    Stability Stable in commonly used aqueous Buffers: 0.01M HCl, 1M NaOH, 70% Acetic Acid, 2% SDS, 30% 2-Propanol
    Storage Buffer 20% Ethanol
    Storage Requirements 4 to 30°C
    Particle Size 45 to 165μm
    Product Type IMAC Sepharose 6 fast flow media
    pH Range 3 to 12

    • Uncharged IMAC resin allows possibility to charge with metal ion of choice for optimized selectivity
    • Used for ions such as histidine-tagged proteins but also untagged recombinant or native proteins
    • High protein binding capacity
    • Coupling chemistry and novel ligand designed to give minimal ligand leakage
    • Available HiTrap™ and HiPrep™ pre-packed formats for easy scale-up and process development


  • Description & Specifications

Related Products

Product Content Feedback

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit